Published date: 29 March 2023
Last edited date: 31 March 2023
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£153,070,000
Procurement reference
CF-1446500D0O000000rwimUAA
Published date
29 March 2023
Closing date
3 May 2023
Closing time
1pm
Contract start date
1 September 2023
Contract end date
31 August 2025
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS National Framework for low molecular weight heparin products and fondaparinux
Offer reference number: CM/PHR/22/5687
Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
More information
Previous notice about this procurement
NHS National Framework for low molecular weight heparin products and fondaparinux
- Opportunity
- Published 29 March 2023
Attachments
-
- Document No. 04a - Quality Assurance Process - CM-PHR-22-5687.pdf
- Document No. 04a - Quality Assurance Process - CM-PHR-22-5687
-
- Document No. 05a - Selectt Offer File CM_PHR_22_5687_01.xml
- Document No. 05a - Selectt Offer File CM_PHR_22_5687_01
-
- Document No. 05b - Tender Product Listing and Usage.xlsx
- Document No. 05b - Tender Product Listing and Usage
-
- Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5687.docx
- Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5687
-
- Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHR-22-5687.docx
- Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHR-22-5687
-
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM-PHR-22-5687.pdf
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM-PHR-22-5687
-
- Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5687.doc
- Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5687
-
- Document No. 02 - Terms of offer - CM-PHR-22-5687.docx
- Document No. 02 - Terms of offer - CM-PHR-22-5687
-
- Document No. 06 - Form of offer - CM-PHR-22-5687.doc
- Document No. 06 - Form of offer - CM-PHR-22-5687
-
- Document No. 07a - Quality control technical sheet - CM-PHR-22-5687.pdf
- Document No. 07a - Quality control technical sheet - CM-PHR-22-5687
-
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022.pdf
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022
-
- Document No. 08 - Confidential information schedule - CM-PHR-22-5687.xls
- Document No. 08 - Confidential information schedule - CM-PHR-22-5687
-
- Document No. 09 - Participating Authorities - CM-PHR-22-5687.xls
- Document No. 09 - Participating Authorities - CM-PHR-22-5687
About the buyer
Contact name
Katie Noonan
Address
2nd Floor Rutland House
RUNCORN
WA7 2ES
GB
Share this notice
Closing: 3 May 2023, 1pm